IMR Press / FBL / Volume 28 / Issue 2 / DOI: 10.31083/j.fbl2802028
Open Access Original Research
Anti-Candida and Antibiofilm Activity of Selected Lamiaceae Essential Oils
Show Less
1 Chair and Department of Medical Microbiology, Poznań University of Medical Sciences, 60-806 Poznań, Poland
2 Department of Biotechnology, Institute of Natural Fibres and Medicinal Plants – National Research Institute, 60-630 Poznań, Poland
3 Division of Perinatology and Women's Disease, Poznań University of Medical Sciences, 60-535 Poznań, Poland
4 Laboratory of Molecular Biology in Division of Perinatology and Women's Diseases, Poznań University of Medical Sciences, 60-535 Poznań, Poland
5 Department of Pharmacology and Phytochemistry, Institute of Natural Fibres and Medicinal Plants – National Research Institute, 62-064 Plewiska, Poland
6 Medical Institute, Podhale State Higher Vocational School, 34-400 Nowy Targ, Poland
*Correspondence: tkarpin@ump.edu.pl (Tomasz M. Karpiński)
Front. Biosci. (Landmark Ed) 2023, 28(2), 28; https://doi.org/10.31083/j.fbl2802028
Submitted: 2 November 2022 | Revised: 30 January 2023 | Accepted: 31 January 2023 | Published: 16 February 2023
Copyright: © 2023 The Author(s). Published by IMR Press.
This is an open access article under the CC BY 4.0 license.
Abstract

Background: Candidiasis is a common oral and vaginal infection. Some papers have presented that the essential oils of Lamiaceae plants can have antifungal activity. This study aimed to investigate the activity of 7 essential oils of the Lamiaceae family with known phytochemical compositions against Candida fungi. Methods: Forty-four strains belonging to six species were tested: C. albicans, C. glabrata, C. guilliermondii, C. krusei, C. parapsilosis, and C. tropicalis. During this investigation, the following methods were used: determination of the minimal inhibitory concentrations (MICs), biofilm inhibition studies, and in silicotoxicity tests. Results: Essential oils of lemon balm (Melissa officinalis) and oregano (Origanum vulgare) showed the best anti-Candida activity, with MIC values below 3.125 mg/mL. Lavender (Lavandula stoechas), mint (Mentha × piperita), rosemary (Rosmarinus officinalis), and thyme (Thymus vulgaris) essential oils were also very active (0.39 to 6.25 or 12.5 mg/mL). Sage (Salvia officinalis) essential oil presented the lowest activity, with MIC values ranging from 3.125 to 100 mg/mL. In an antibiofilm study using MIC values, oregano and thyme essential oils showed the greatest effect, followed by lavender, mint, and rosemary oils. The weakest antibiofilm activity was observed with the lemon balm and sage oils. In silico toxicity research suggests that most of main compounds of Lamiaceae essential oils probably do not exhibit carcinogenicity, mutagenicity, or cytotoxicity. Conclusions: The obtained results showed that Lamiaceae essential oils have anti-Candida and antibiofilm activity. Further research is required to confirm the safety and efficacy of essential oils in the topical treatment of candidiasis.

Keywords
essential oils
antifungal
antibiofilm
Lamiaceae
phytocompounds
drug sensitivity
in silico
toxicity
1. Introduction

Fungal infections are the leading cause of changes in oral and vaginal mucous membranes. Among others, the incidence of fungal infections is related to one’s status as a carrier of the genus Candida, which affects as much as 30% of the population. Oral candidiasis occurs in 4% of people, and its frequency increases in patients with diabetes mellitus, immunodeficiency, or following antibiotic use [1, 2]. The most frequently detected yeast-like fungus in the oral cavity is Candida albicans. Among non-albicans Candida species, C. glabrata, C. tropicalis, C. parapsilosis, and C. krusei predominate [2, 3, 4]. In the case of mucosal fungal infections, the most frequently identified yeast-like species depend on the study area. In Europe, the most common isolates were C. albicans (80–87%), C. glabrata (4.2–5.8%), S. cerevisiae (5.5%), C. krusei (1.6–3.2%) and C. tropicalis (2.1–2.2%). Other identified species from patient samples include C. dubliniensis, C. famata, C. guilliermondii, C. kefyr, and C. parapsilosis [5, 6]. However, in Asia the incidence of C. albicans infections was lower than in Europe (51–75%). Other Candida infections were caused by C. parapsilosis (0.7–26%), C. glabrata (2.0–23%), C. tropicalis (1.8–6.1%), C. krusei (2.8–3.9%), C. krusei (2.8%) and C. africana (1.6%) [3, 4, 7].

Antifungal drugs are used to treat candidiasis and other yeast-like infections. However, the search for new medicines is constantly ongoing. Many natural substances, including essential oils, have antifungal properties and can be used to treat fungal diseases. Essential oils are found in many plants, including those belonging to the following families: Acoraceae, Apiaceae, Asteraceae, Cupressaceae, Geraniaceae, Illiciaceae, Lamiaceae, Lauraceae, Myristicaceae, Myrtaceae, Oleaceae, Pinaceae, Poaceae, Rosaceae, Santalaceae, and Zingiberaceae [8]. Essential oils from the Lamiaceae family are particularly important in traditional medicine, pharmacology, as well as the food industry. Species in this family are rich in terpenes possessing antifungal properties (e.g., camphor, carvacrol, 1,8-cineole, citral, p-cymene, geraniol, linalool, menthols, pinenes, terpinenes, thujones, and thymol) [9].

Today we know that essential oils have been used for millennia. Archaeological evidence suggests their use as early as the Neolithic Age (before 4000 B.C.). Information about them is also contained in ancient accounts from Mesopotamia and Egypt [10]. Essential oils are used in aromatherapy, bathing, massages, wound healing, as well as in the treatment of headache, muscular pain, respiratory problems, skin changes, and joint inflammation [10, 11]. Essential oils are likewise used in toothpastes and mouth rinses to protect against dental caries, periodontal diseases, and candidiasis [12, 13, 14]. Furthermore, essential oils are used in the treatment of vaginitis [15, 16]. They have a broad range of therapeutically beneficial effects, including antioxidant and anti-inflammatory properties, as well as antibacterial, antifungal, and antibiofilm activity [17, 18, 19].

This study aimed to investigate the antifungal and antibiofilm activity of seven essential oils of the Lamiaceae family. In total, 44 Candida strains, mainly clinical isolates belonging to six species, were tested in vitro. Additionally, in silico toxicity prediction was performed for the main essential oils used in the investigation.

2. Materials and Methods
2.1 Essential Oils

Essential oils were purchased in Etja (Elbląg, Poland). All oils were stored at 4 °C, with an expiration date of 2023 or 2024. This study made use of seven essential oils from the Lamiaceae family, namely from Lavandula stoechas L., Melissa officinalis L., Mentha × piperita L., Origanum vulgare L., Rosmarinus officinalis L., Salvia officinalis L. and Thymus vulgaris L. Table 1 shows the phytochemical composition of the oils according to the data obtained from the manufacturer.

Table 1.Phytochemical composition of essential oils used in the studies according to the data obtained from the manufacturer (Etja, Elbląg, Poland).
No. Plant Composition
1 Lavandula stoechas L. 35% linalool, 35% linalyl acetate, 4% caryophyllene, 3% ocimenes, 2% 1,8-cineole, 1.5% α-terpineol, 1% d-limonene, 0.5% camphor
2 Melissa officinalis L. 15–30% citral, 3–6% geraniol, 3–5% citronellol, 3–5% citronellal, 1–3% isopulegol, 1% linalool, 1% limonene
3 Mentha × piperita L. 40% menthols, 20% menthones, 5% l-menthyl acetate, 5% 1,8-cineole, 3% d-limonene, 2% α-pinene, 2% caryophyllene, 2% menthofuran, 1% pulegones, 0.4% piperitones
4 Origanum vulgare L. 50% carvacrol, 1–10% α-terpinene, 1–10% linalool, 1–10% myrcene, 1–10% p-cymene, 1–10% thymol, 0.1–1% α-pinene, 0.1–1% β-pinene, 0.1–1% limonene
5 Rosmarinus officinalis L. 45% 1,8-cineole (eucalyptol), 15% α-pinene, 12% camphor, 4% camphene, 3% borneol, 3% caryophyllene, 2% α-terpineol, 1% myrcene, 1% p-cymene, 0.7% linalool
6 Salvia officinalis L. 33% thujones, 20% camphor, 10% 1,8-cineole, 8% α-pinene, 6% camphene, 4% caryophyllene, 2% borneol, 2% d-limonene, 1.4% terpinene-4-ol, 1% myrcene
7 Thymus vulgaris L. 30–40% p-cymene, <30% thymol, 2-4% α-pinene, 0.5–1.5% limonene, <1% β-pinene
2.2 Fungal Strains

During the in vitro tests, strains from the Chair and Department of Medical Microbiology collection at the Poznań University of Medical Sciences were used. The tests were performed on C. albicans (16 strains), C. glabrata (8 strains), C. krusei (8 strains), C. parapsilosis (4 strains), C. tropicalis (4 strains), and C. guilliermondii (2 strains). All clinical strains were obtained from patients’ mucous membranes and were identified using the Integral System Yeasts Plus (Graso Biotech, Starogard Gdański, Poland) biochemical test. The experiments also included the following reference strains: C. albicans ATCC 14053 and C. glabrata ATCC 66032. All species were grown at 35 °C for 24 h in Sabouraud dextrose agar (Graso Biotech).

2.3 Antimicrobial Activity (MIC)

The minimal inhibitory concentrations (MICs) of selected essential oils were determined by the micro-dilution method using 96-well plates (NUNC, USA and Nest Scientific Biotechnology, Jiangsu, China). The studies were conducted according to the methodology described in our previous publications [20, 21]. Briefly, 90 μL of tryptic soy broth (Graso Biotech) and 10 μL of fungi suspension were placed into each well to a final inoculum concentration of 106 CFU/mL. Suspension was performed using McFarland standards and microscopy [22]. Before studies, essential oils were emulsified in tryptic soy broth (1:1) using Omni TH homogenizer (Omni, Kennesaw, GA, USA).

Serial dilutions of each essential oil were performed to obtain concentrations ranging from 200 to 0.1 mg/mL. The plates were incubated at 35 °C for 24 h. The MIC value was the lowest essential oil concentration that inhibited any visible fungal growth. Optical density (OD) was measured at 620 nm using a microtiter plate reader (Eppendorf, Warszawa, Poland). Additionally, 10 μL of a 1% aqueous solution of XTT (Sigma Aldrich, Poznań, Poland) was added to each well. Microorganisms convert tetrazolium compounds to a colored water-soluble formazan product [20, 21, 23, 24]. All the experiments were performed in triplicate.

2.4 Biofilm Inhibition

The inhibition of biofilm formation by C. albicans (ATCC 14053), the C. albicans, C. glabrata and C. krusei clinical strains was evaluated by means of a crystal violet assay. The influence of essential oils at the concentrations of MIC was determined. The negative control was a sterile culture medium. At first, suspension of each yeast was performed at a concentration of 106 CFU/mL [25]. The biofilm was formed in 96-well plates with tryptic soy broth, after the addition of the appropriate essential oil to its previously determined MIC and 10 μL of fungal suspension. The total volume in wells was 100 μL. Next, plates were incubated for 48 hours at 37 °C. After incubation, the wells were washed with 200 μL of PBS three times, and plates were dried by inverting them on absorbent paper for 15 min. Each well was fixed with 200 μL of methanol for 15 min and dried after removing it. Afterward, the wells were stained with 200 μL of 1% crystal violet solution for 20 minutes. Wells were washed thrice with PBS, dried, and 200 μL of 96% ethanol was added to dissolve the crystal violet [26]. To quantify the biofilm, the optical density (OD) was measured at 620 nm, using an Elisa Reader 250 (bioMerieux, Marcy-l’Étoile, France). The percentage of biofilm biomass growth was determined using the following formula:

% Biofilm growth = 100 × (Sample OD620 – Control OD620) / (Control OD620)

2.5 In Silico Toxicity Prediction

The toxicity of the main compounds found in the studied Lamiaceae essential oils presented in Table 1 was determined using in silico methods. Specifically, the ProTox-II (https://tox-new.charite.de/protox_II) [27] and pkCSM (http://biosig.unimelb.edu.au/pkcsm/) [28] software were used. Studies were performing according to software manuals.

2.6 Statistics

The mean, SD and median of MIC values of essential oils against Candida strains were calculated. The Kruskal–Wallis and post-hoc tests were applied to determine the statistical significance of differences in the MICs of fungi. The results were considered significant at the level of p < 0.05. Data were tested using InStat3 software (GraphPad Software, Boston, MA, USA).

3. Results
3.1 Antimicrobial Activity (MIC)

Essential oils inhibited the growth of the tested strains of Candida at concentrations of 0.1–100 mg/mL (Fig. 1). The essential oils obtained from lemon balm and oregano showed the best anti-Candida activity. The MIC value for both oils was below 3.125 mg/mL. Lavender, mint, rosemary, and thyme essential oils were also very active in the range of 0.39 to 6.25 or 12.5 mg/mL. The essential oil obtained from sage exhibited statistically the weakest activity with MIC values ranging from 3.125 to 100 mg/mL for single C. krusei and C. parapsilosis strains. These results suggest that strains of C. krusei are the least sensitive to Lamiaceae essential oils. The activity of each essential oil against various Candida strains is outlined in Table 2 and Supplementary Tables 1–7. Statistical analysis of the mean MICs values (mg/mL) for selected Lamiaceae essential oils obtained for all Candida strains is presented in Table 3.

Fig. 1.

Representative MIC determination setup for 6 tested Candida species on 96-well plates. Pink color indicates fungal growth.

Table 2.The activity (MIC — minimal inhibitory concentration) of selected Lamiaceae essential oil against Candida strains.
Plant species Yeast-like fungi
MICs (mg/mL) mean ± SD [median]
C. albicans C. glabrata C. krusei C. parapsilosis C. tropicalis C. guilliermondii
Lavandula stoechas 1.47 ± 0.9 1.08 ± 0.47 3.12 ± 1.45 1.37 ± 0.39 1.76 ± 0.98 0.78 ± 0.0
[1.56] [0.78] [3.125] [1.56] [1.56] [0.78]
Melissa officinalis 0.78 ± 0.9 0.78 ± 0.34 1.41 ± 0.83 0.49 ± 0.2 0.68 ± 0.2 0.39 ± 0.0
[0.39] [0.78] [1.56] [0.39] [0.78] [0.39]
Mentha × piperita 2.27 ± 1.37 2.78 ± 0.69 6.64 ± 3.9 2.34 ± 0.9 2.73 ± 0.78 1.56 ± 0.0
[1.56] [3.125] [6.25] [2.343] [3.125] [1.56]
Origanum vulgare 0.83 ± 0.71 1.08 ± 0.47 2.05 ± 0.93 0.88 ± 0.5 0.83 ± 0.56 0.59 ± 0.28
[0.78] [0.78] [1.56] [0.78] [0.78] [0.59]
Rosmarinus officinalis 1.91 ± 1.38 1.56 ± 0.68 7.81 ± 4.09 3.52 ± 1.97 2.73 ± 0.78 2.34 ± 1.11
[1.56] [1.56] [6.25] [3.125] [3.125] [2.34]
Salvia officinalis 16.36 ± 11.02 20.14 ± 13.18 29.69 ± 29.08 50 ± 35.36 14.06 ± 7.86 18.75 ± 8.84
[12.5] [12.5] [25] [37.5] [12.5] [18.75]
Thymus vulgaris 4.16 ± 3.63 1.56 ± 0.68 6.45 ± 4.13 0.88 ± 0.49 2.15 ± 1.17 1.56 ± 0.0
[3.125] [1.56] [6.25] [0.78] [2.343] [1.56]
Table 3.Statistical analysis (p values) of the mean MICs values (mg/mL) for selected Lamiaceae essential oils against Candida strains.
Plant species (mean of MICs) L. stoechas M. officinalis M. × piperita O. vulgare R. officinalis S. officinalis T. vulgaris
(1.67) (0.84) (3.186) (1.1) (3.15) (22.5) (3.44)
Lavandula stoechas - <0.05 <0.05 ns ns <0.001 ns
Melissa officinalis <0.05 - <0.001 ns <0.001 <0.001 <0.001
Mentha × piperita <0.05 <0.001 - <0.001 ns <0.001 ns
Origanum vulgare ns ns <0.001 - <0.001 <0.001 <0.001
Rosmarinus officinalis ns <0.001 ns <0.001 - <0.001 ns
Salvia officinalis <0.001 <0.001 <0.001 <0.001 <0.001 - <0.001
Thymus vulgaris ns <0.001 ns <0.001 ns <0.001 -
3.2 Biofilm Inhibition

The antibiofilm study using Lamiaceae essential oils yielded various results. At the MIC values, oregano and thyme essential oils showed the strongest effect, inhibiting biofilm growth by about 90%. Lavender, mint, and rosemary oils at the MIC concentration inhibited biofilm growth by about 75–85%. The weakest antibiofilm activity was observed with lemon balm and sage oils, which destroy only about 60–70% of biofilm. Interestingly, lemon balm essential oil exhibited the strongest anti-Candida activity in the planktonic form, while it exerted a much weaker inhibitory effect in the antibiofilm study. The antibiofilm activity of the studied Lamiaceae essential oils at the MICs are presented in Fig. 2.

Fig. 2.

Antibiofilm activity of Lamiaceae essential oils against Candida albicans ATCC 14053 and three clinical strains of C. albicans, C. glabrata and C. krusei.

3.3 In Silico Toxicity Prediction

In silico toxicity studies revealed that most of the main compounds found in the Lamiaceae essential oils used in this investigation did not exhibit carcinogenicity, mutagenicity, or cytotoxicity. Only p-cymene has carcinogenic activity, while menthone exhibited mutagenic activity. 16 out of 21 compounds were found to have the potential to lead to skin sensitization (Table 4, Ref. [27, 28]). This means that Lamiaceae essential oils can irritate the skin and should only be applied for short periods of time. With the exception of p-cymene, all of the tested compounds have high lethal dose 50 (LD50) values, which means that they are relatively safe for use in the oral cavity, even if ingested.

Table 4.Toxicity of the main Lamiaceae essential oil compounds determined using the in silico ProTox-II and pkCSM online software tools [27, 28].
Compound Predicted LD50 [mg/kg] Skin sensitization Carcinogenicity Mutagenicity Cytotoxicity
Camphene 5000 No No No No
Camphor 775 No No No No
Carvacrol 810 Yes No No No
Caryophyllene 5300 Yes No No No
1,8-Cineole (Eucalyptol) 2480 Yes No No No
Citral 500 Yes No No No
Citronellal 2420 Yes No No No
Citronellol 3450 Yes No No No
p-Cymene 3 Yes Yes No No
Geraniol 2100 Yes No No No
Limonene 4400 Yes No No No
Linalool 2200 Yes No No No
Linalyl Acetate 12,000 Yes No No No
Menthol 940 Yes No No No
Menthone 500 Yes No Yes No
L-Menthyl Acetate 3200 Yes No No No
Myrcene 5000 No No No No
α-Pinene 3700 No No No No
α-Terpinene 1680 No No No No
Thujone 500 Yes No No No
Thymol 640 Yes No No No
4. Discussion

Volatile oils obtained from Lamiaceae plants contain various groups of chemical compounds such as monoterpenes, sesquiterpenes as well as phenolics. Depending on the major chemical compounds, several chemotypes have been described [29]. It has been well established, that the chemical composition of essential oils is influenced by environmental factors, geographical regions of plant growth, harvesting time, the stage of plant development [30]. Popular extraction methods used to isolate essential oils, include conventional hydrodistillation (HD) [31, 32, 33], and vacuum distillation [34]. These methods of distillation are described in the European Pharmacopoeia. Other methods of distillation are likewise used and include enzyme-assisted hydrodistillation [35], and water microwave assisted hydrodistillation (MAHD) techniques [36, 37]. However, no significant differences were found in composition of Lamiaceae essential oils after the comparison of MAHD and HD [36]. Another innovative method is supercritical fluid extraction (SFE) of volatile oils, which allows for higher essential oil yield and the isolation of more chemical compounds when compared to the more traditional hydrodistillation process [38]. In contrast, Rodriguez-Solana et al. [39] found that the highest extraction yields were obtained using the Soxlet and accelerated solvent (ASE) techniques (but not SFE) in case of Mentha piperita and Rosmarinus officinalis. To identify and quantity of chemical constituents of a given essential oil, the method of choice is gas chromatography with mass spectrometry (GC-MS) [33] and GC with flame ionization detector (GC-FID) [33, 39].

Data found in the literature indicate considerable variability regarding the antifungal activity of essential oils. These differences are likely related to the different biochemical composition of essential oils, which depend on the place of harvest, soil and light conditions, and the harvest date [40]. Another critical factor is the method of obtaining essential oils, which can lead to significantly different concentrations of active compounds [41].

In this study, the active concentrations of essential oils ranged between 0.1 to 100 mg/mL. Essential oil from lavender acted against Candida strains at concentrations between 0.39–6.25 mg/mL. These values differ markedly from those available in the published literature available to date. In the study by Khoury et al. [42], the MIC of Lavandula stoechas oil against C. albicans was found to be 0.5 mg/mL. This value was similar to that obtained during this investigation. However, Zuzarte et al. [43] reported that the MICs of Lavandula stoechas oil against C. albicans, C. guillermondii, C. krusei, C. parapsilosis, and C. tropicalis were very low, ranging between 0.64–2.5 μg/mL.

Based upon the results obtained in this investigation, the essential oils from melissa and oregano have the best antifungal activity (MICs from 0.2 up to 3.125 mg/mL). Other Polish studies have shown the sensitivity of yeast-like fungi to melissa oil to be in the concentration range of 0.25–2.0 mg/mL. Most strains of C. albicans, C. glabrata, and C. humicola were inhibited at concentrations of 0.25–0.5 mg/mL. In contrast, MIC values for C. kefyr, C. krusei, C. lusitaniae and C. tropicalis strains were in the range of 0.5–2.0 mg/mL [44]. Similarly, a study from the USA found that melissa oil exhibited a MIC of 0.3 mg/mL against C. albicans [45]. In research from Italy, MICs against C. krusei, C. parapsilosis, C. valida, C. lusitaniae, and C. norvegensis were found to be 0.3–1.2 mg/mL [46]. In the case of oregano oil, the literature shows a similar MIC range (0.26–2.5 mg/mL) against Candida species [45, 46, 47, 48] as that obtained in this study.

The present study found that peppermint oil, rosemary oil, and thyme oil exhibit similar strength against Candida strains, with MIC values ranging from 0.39 to 12.5 mg/mL. In other publications, these values were at the level of 0.23–1.1 mg/mL for Mentha piperita oil [45, 49, 50] and 0.22–3.13 mg/mL for Rosmarinus officinalis oil [42, 45, 47, 48, 51]. In the study by Kędzia and Hołderna-Kędzia, rosemary oil inhibited the growth of yeast-like fungi at a concentration of 7.5–15 mg/mL. Strains of C. utilis, C. guilliermondii, and C. kefyr are most susceptible to rosemary oil, while C. tropicalis, C. krusei, and C. lusitaniae are the most resistant [52]. In the case of thyme, there are large differences in the MIC values. The lowest reported MIC values of thyme oil against C. albicans, C. tropicalis, C. glabrata, C. krusei, C. guillermondii, and C. parapsilosis were 0.08–0.32 μg/mL [53]. In contrast, another paper reported that the MIC of thyme oil against C. albicans was 313 μg/mL [45]. In two articles published in 2021, the MIC values for Thymus vulgaris oil against Candida species were 0.4–0.6 mg/mL [46, 48].

Essential oil from a sage was the only one for which this study revealed a MIC value of up to 100 mg/mL. High active concentrations of Salvia officinalis oil against Candida were also reported by Mandras et al. [46] and Proškovcová et al. [48]. The MIC values obtained in those studies were 2.5–10 mg/mL and 3.13–50 mg/mL, respectively. A study by Sookto et al. [54] demonstrated a MIC value of 2.78 mg/mL. However, one study from 2013 reported very low MICs in the range of 1.25–5 μg/mL against C. albicans, C. tropicalis, C. krusei, C. guillermondii, and C. parapsilosis [55].

The presented results of anti-biofilm activity indicate that essential oils from Origanum vulgare and Thymus vulgaris have the strongest effect, which at a concentration of 1 MIC destroyed about 90% of biofilm. Oils from Lavandula stoechas, Mentha × piperita and Rosmarinus officinalis showed a weaker effect, destroying about 75–85% of the biofilm. Essential oils from Melissa officinalis and Salvia officinalis had the weakest activity, destroying only about 60–70% of the biofilm.

In the article by Proškovcová et al. [56], C. albicans biofilm reduction by Origanum vulgare, Rosmarinus officinalis and Thymus vulgaris essential oils was 63.8–69.2%, which means that it was lower than that obtained in our study. It is interesting, that biofilm reduction by Salvia officinalis essential oil was the highest (70.6%) [56], but in our results was least, notwithstanding percentage was similar. Unfortunately, the results of biofilm formation inhibition may differ significantly, as exemplified by 2 publications. In paper by Benzaid et al. [57] the MIC concentration of Mentha x piperita essential oil causing C. albicans biofilm inhibition was 10 μg/mL, and Agarval et al. [58] demonstrated this effect at a MIC of 800 μg/mL. These differences may be related among others to with different composition of essential oils or other research methodology [9]. It is surprising, however, that also in the case of individual chemical compounds these differences can be very large. A study of thymol on biofilm formation by Jafri and Ahmad [59] indicated that it was active at a concentration of 3.12 μg/mL. However, in the studies of Braga et al. [60] the required concentration was as high as 125 μg/mL.

A significant advantage of this investigation is the inclusion of a large number of both essential oils and Candida strains. Very often, only single reference strains are tested by other authors [42, 45, 50, 51, 54, 55]. Additionally, many publications do not include clinical strains [42, 45, 47, 49, 50, 51, 54, 55]. Unfortunately, as can be seen in the tables presented above there are often notable differences in the sensitivity of fungi from the same species to the same essential oil. An excellent example of this variability is the activity of Thymus vulgaris essential oil against C. albicans, for which the MIC values range from 0.39 up to 12.5 mg/mL. Such differences cannot be readily appreciated when testing only one strain per species.

The use of several species allows for the demonstration of interspecies differences in the sensitivity to plant compounds within a given genus. One such notable example from this study is the low sensitivity of C. krusei to essential oils compared to other species of the Candida genus. Such differences cannot be elucidated by studies in which only one species of a given genus was tested [42, 45, 47, 48, 50, 51, 54]. Furthermore, in the case of natural substances, phytochemical analysis is important, allowing for the comparison of substances originating, for example, from different regions of the world or isolated using different methods. Unfortunately, in some publications, phytochemical data are not included or data from the general literature is provided, this does not accurately reflect the actual composition of the substances used in the studies [44, 52, 54].

The large number of clinical Candida isolates used in this investigation lends to its broad applicability. Most of the available literature focuses on single reference strains with clinical isolates being excluded entirely [42, 45, 47, 49, 50, 51, 54, 55]. To the best of our knowledge, this is the first study to investigate the in silico toxicity prediction of the main compounds of Lamiaceae essential oils. The present investigation also demonstrates via in silico methods that the majority of the compounds in the Lamiaceae essential oils used in this study do not exhibit toxicity. Unfortunately, there are few publications assessing the toxicity of the essential oils or their constituent compounds used in the present study. In the available studies on mice and rats, essential oils and extracts from Lamiaceae are non-toxic or slightly toxic [61, 62, 63]. These studies lend support to the in silico findings reported here.

5. Conclusions

Essential oils from lemon balm and oregano exerted the most potent anti-Candida activity, with MIC values below 3.125 mg/mL. Lavender, mint, rosemary, and thyme essential oils also inhibit growth in the range of 0.39 to 6.25 or 12.5 mg/mL. The weakest activity was observed with sage essential oil, for which the MIC values ranged from 3.125 to 100 mg/mL for single C. krusei and C. parapsilosis strains. All tested essential oils can also inhibit Candida albicans biofilm formation. The majority of main compounds found in the Lamiaceae essential oils used in this study did not exhibit toxicity in silico, but probably can sensitize the skin.

Availability of Data and Materials

All data generated or analyzed during this study are included in this published article.

Author Contributions

Conceptualization—TMK and MO; methodology—TMK; investigation—TMK, MO and ASM; writing - original draft preparation—TMK, ASM and HW; writing - review and editing—MO and HW; supervision—TMK and ASM; funding acquisition—TMK and MO. All authors have read and agreed to the published version of the manuscript.

Ethics Approval and Consent to Participate

Not applicable.

Acknowledgment

Not applicable.

Funding

This research received no external funding.

Conflict of Interest

Given their role as Guest Editors, Tomasz M. Karpiński and Marcin Ożarowski had no involvement in the peer-review of this article and have no access to information regarding its peer-review. Full responsibility for the editorial process for this article was delegated to Graham Pawelec. The authors declare no conflict of interest.

References
[1]
Jacob L, John M, Kalder M, Kostev K. Prevalence of vulvovaginal candidiasis in gynecological practices in Germany: A retrospective study of 954,186 patients. Current Medical Mycology. 2018; 4: 6–11.
[2]
Patil S, Rao RS, Majumdar B, Anil S. Clinical Appearance of Oral Candida Infection and Therapeutic Strategies. Frontiers in Microbiology. 2015; 6: 1391.
[3]
Hu L, He C, Zhao C, Chen X, Hua H, Yan Z. Characterization of oral candidiasis and the Candida species profile in patients with oral mucosal diseases. Microbial Pathogenesis. 2019; 134: 103575.
[4]
Sato T, Kishi M, Suda M, Sakata K, Shimoda H, Miura H, et al. Prevalence of Candida albicans and non-albicans on the tongue dorsa of elderly people living in a post-disaster area: a cross-sectional survey. BMC Oral Health. 2017; 17: 51.
[5]
Babic M, Hukic M. Candida albicans and non-albicans species as etiological agent of vaginitis in pregnant and non-pregnant women. Bosnian Journal of Basic Medical Sciences. 2010; 10: 89–97.
[6]
Macura AB, Skóra M. Fungi isolated from the vagina and their susceptibility to antifungals. Ginekologia Polska. 2012; 83: 433–438. (In Polish)
[7]
Anh DN, Hung DN, Tien TV, Dinh VN, Son VT, Luong NV, et al. Prevalence, species distribution and antifungal susceptibility of Candida albicans causing vaginal discharge among symptomatic non-pregnant women of reproductive age at a tertiary care hospital, Vietnam. BMC Infectious Diseases. 2021; 21: 523.
[8]
Franz C, Novak J. Sources of Essential Oils. CRC Press Taylor & Francis Group: Boca Raton, FL, USA, 2010.
[9]
Karpiński TM. Essential Oils of Lamiaceae Family Plants as Antifungals. Biomolecules. 2020; 10: 103.
[10]
Cimino C, Maurel OM, Musumeci T, Bonaccorso A, Drago F, Souto EMB, et al. Essential Oils: Pharmaceutical Applications and Encapsulation Strategies into Lipid-Based Delivery Systems. Pharmaceutics. 2021; 13: 327.
[11]
Ali B, Al-Wabel NA, Shams S, Ahamad A, Khan SA, Anwar F. Essential oils used in aromatherapy: A systemic review. Asian Pacific Journal of Tropical Biomedicine. 2015; 5: 601–611.
[12]
Ardizzoni A, Pericolini E, Paulone S, Orsi CF, Castagnoli A, Oliva I, et al. In vitro effects of commercial mouthwashes on several virulence traits of Candida albicans, viridans streptococci and Enterococcus faecalis colonizing the oral cavity. PLoS ONE. 2018; 13: e0207262.
[13]
de Oliveira Carvalho I, Purgato GA, Píccolo MS, Pizziolo VR, Coelho RR, Diaz-Muñoz G, et al. In vitro anticariogenic and antibiofilm activities of toothpastes formulated with essential oils. Archives of Oral Biology. 2020; 117: 104834.
[14]
Machorowska-Pieniążek A, Morawiec T, Olek M, Mertas A, Aebisher D, Bartusik-Aebisher D, et al. Advantages of using toothpaste containing propolis and plant oils for gingivitis prevention and oral cavity hygiene in cleft lip/palate patients. Biomedicine & Pharmacotherapy. 2021; 142: 111992.
[15]
Abd Ellah NH, Shaltout AS, Abd El Aziz SMM, Abbas AM, Abd El Moneem HG, Youness EM, et al. Vaginal suppositories of cumin seeds essential oil for treatment of vaginal candidiasis: Formulation, in vitro, in vivo, and clinical evaluation. European Journal of Pharmaceutical Sciences. 2021; 157: 105602.
[16]
Campelo MS, Melo EO, Arrais SP, do Nascimento FBSA, Gramosa NV, Soares SA, et al. Clove essential oil encapsulated on nanocarrier based on polysaccharide: A strategy for the treatment of vaginal candidiasis. Colloids and Surfaces A: Physicochemical and Engineering Aspects. 2021; 610: 125732.
[17]
Aebisher D, Cichonski J, Szpyrka E, Masjonis S, Chrzanowski G. Essential Oils of Seven Lamiaceae Plants and Their Antioxidant Capacity. Molecules (Basel, Switzerland). 2021; 26: 3793.
[18]
Dagli N, Dagli R, Mahmoud RS, Baroudi K. Essential oils, their therapeutic properties, and implication in dentistry: A review. Journal of International Society of Preventive & Community Dentistry. 2015; 5: 335–340.
[19]
Karpiński TM, Ożarowski M, Seremak-Mrozikiewicz A, Wolski H, Adamczak A. Plant Preparations and Compounds with Activities against Biofilms Formed by Candida spp. Journal of Fungi. 2021; 7: 360.
[20]
Adamczak A, Ożarowski M, Karpiński TM. Antibacterial Activity of Some Flavonoids and Organic Acids Widely Distributed in Plants. Journal of Clinical Medicine. 2019; 9: 109.
[21]
Adamczak A, Ożarowski M, Karpiński TM. Curcumin, a Natural Antimicrobial Agent with Strain-Specific Activity. Pharmaceuticals. 2020; 13: 153.
[22]
Guinea J, Recio S, Escribano P, Torres-Narbona M, Peláez T, Sánchez-Carrillo C, et al. Rapid antifungal susceptibility determination for yeast isolates by use of Etest performed directly on blood samples from patients with fungemia. Journal of Clinical Microbiology. 2010; 48: 2205–2212.
[23]
Loures FV, Levitz SM. XTT Assay of Antifungal Activity. Bio-protocol. 2015; 5: e1543.
[24]
Karpiński TM, Adamczak A. Fucoxanthin-An Antibacterial Carotenoid. Antioxidants. 2019; 8: 239.
[25]
Ratajczak M, Kamińska D, Nowak-Malczewska DM, Schneider A, Dlugaszewska J. Relationship between antibiotic resistance, biofilm formation, genes coding virulence factors and source of origin of Pseudomonas aeruginosa clinical strains. Annals of Agricultural and Environmental Medicine. 2021; 28: 306–313.
[26]
Krzyżek P, Migdał P, Paluch E, Karwańska M, Wieliczko A, Gościniak G. Myricetin as an Antivirulence Compound Interfering with a Morphological Transformation into Coccoid Forms and Potentiating Activity of Antibiotics against Helicobacter pylori. International Journal of Molecular Sciences. 2021; 22: 2695.
[27]
Banerjee P, Eckert AO, Schrey AK, Preissner R. ProTox-II: a webserver for the prediction of toxicity of chemicals. Nucleic Acids Research. 2018; 46: W257–W263.
[28]
Pires DEV, Blundell TL, Ascher DB. pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures. Journal of Medicinal Chemistry. 2015; 58: 4066–4072.
[29]
Lombrea A, Antal D, Ardelean F, Avram S, Pavel IZ, Vlaia L, et al. A Recent Insight Regarding the Phytochemistry and Bioactivity of Origanum vulgare L. Essential Oil. International Journal of Molecular Sciences. 2020; 21: 9653.
[30]
Fikry S, Khalil N, Salama O. Chemical profiling, biostatic and biocidal dynamics of Origanum vulgare L. essential oil. AMB Express. 2019; 9: 41.
[31]
Bora L, Burkard T, Juan MHS, Radeke HH, Muț AM, Vlaia LL, et al. Phytochemical Characterization and Biological Evaluation of Origanum vulgare L. Essential Oil Formulated as Polymeric Micelles Drug Delivery Systems. Pharmaceutics. 2022; 14: 2413.
[32]
Jassbi AR, Asadollahi M, Masroor M, Schuman MC, Mehdizadeh Z, Soleimani M, et al. Chemical classification of the essential oils of the Iranian Salvia species in comparison with their botanical taxonomy. Chemistry & Biodiversity. 2012; 9: 1254–1271.
[33]
Lim Ah Tock MJ, Kamatou GPP, Combrinck S, Sandasi M, Viljoen AM. A chemometric assessment of essential oil variation of three Salvia species indigenous to South Africa. Phytochemistry. 2020; 172: 112249.
[34]
Rostro-Alanis MDJ, Báez-González J, Torres-Alvarez C, Parra-Saldívar R, Rodriguez-Rodriguez J, Castillo S. Chemical Composition and Biological Activities of Oregano Essential Oil and Its Fractions Obtained by Vacuum Distillation. Molecules. 2019; 24: 1904.
[35]
Mohamad N, Ramli N, Abd-Aziz S, Ibrahim MF. Comparison of hydro-distillation, hydro-distillation with enzyme-assisted and supercritical fluid for the extraction of essential oil from pineapple peels. 3 Biotech. 2019; 9: 234.
[36]
Liu B, Fu J, Zhu Y, Chen P. Optimization of Microwave-assisted Extraction of Essential Oil from Lavender Using Response Surface Methodology. Journal of Oleo Science. 2018; 67: 1327–1337.
[37]
Presti ML, Ragusa S, Trozzi A, Dugo P, Visinoni F, Fazio A, et al. A comparison between different techniques for the isolation of rosemary essential oil. Journal of Separation Science. 2005; 28: 273–280.
[38]
Wu H, Li J, Jia Y, Xiao Z, Li P, Xie Y, et al. Essential Oil Extracted from Cymbopogon citronella Leaves by Supercritical Carbon Dioxide: Antioxidant and Antimicrobial Activities. Journal of Analytical Methods in Chemistry. 2019; 2019: 8192439.
[39]
Rodríguez-Solana R, Salgado JM, Domínguez JM, Cortés-Diéguez S. Comparison of Soxhlet, accelerated solvent and supercritical fluid extraction techniques for volatile (GC-MS and GC/FID) and phenolic compounds (HPLC-ESI/MS/MS) from Lamiaceae species. Phytochemical Analysis: PCA. 2015; 26: 61–71.
[40]
Ćavar S, Vidic D, Maksimović M. Volatile constituents, phenolic compounds, and antioxidant activity of Calamintha glandulosa (Req.) Bentham. Journal of the Science of Food and Agriculture. 2013; 93: 1758–1764.
[41]
Khoury M, Stien D, Eparvier V, Ouaini N, El Beyrouthy M. Report on the Medicinal Use of Eleven Lamiaceae Species in Lebanon and Rationalization of Their Antimicrobial Potential by Examination of the Chemical Composition and Antimicrobial Activity of Their Essential Oils. Evidence-based Complementary and Alternative Medicine. 2016; 2016: 2547169.
[42]
Zuzarte M, Gonçalves MJ, Cruz MT, Cavaleiro C, Canhoto J, Vaz S, et al. Lavandula luisieri essential oil as a source of antifungal drugs. Food Chemistry. 2012; 135: 1505–1510.
[43]
Kędzia A, Kędzia AW. Antifungal activity of Melissa oil (Oleum Melissae). Postępy Fitoterapii. 2020; 21: 14–18 .
[44]
Powers CN, Osier JL, McFeeters RL, Brazell CB, Olsen EL, Moriarity DM, et al. Antifungal and Cytotoxic Activities of Sixty Commercially-Available Essential Oils. Molecules. 2018; 23: 1549.
[45]
Mandras N, Roana J, Scalas D, Del Re S, Cavallo L, Ghisetti V, et al. The Inhibition of Non-albicans Candida Species and Uncommon Yeast Pathogens by Selected Essential Oils and Their Major Compounds. Molecules. 2021; 26: 4937.
[46]
Elansary HO, Abdelgaleil SAM, Mahmoud EA, Yessoufou K, Elhindi K, El-Hendawy S. Effective antioxidant, antimicrobial and anticancer activities of essential oils of horticultural aromatic crops in northern Egypt. BMC Complementary and Alternative Medicine. 2018; 18: 214.
[47]
Proškovcová M, Čonková E, Váczi P, Harčárová M, Malinovská Z. Antibiofilm activity of selected plant essential oils from the Lamiaceae family against Candida albicans clinical isolates. Annals of Agricultural and Environmental Medicine. 2021; 28: 260–266.
[48]
Samber N, Khan A, Varma A, Manzoor N. Synergistic anti-candidal activity and mode of action of Mentha piperita essential oil and its major components. Pharmaceutical Biology. 2015; 53: 1496–1504.
[49]
Tyagi AK, Malik A. Liquid and vapour-phase antifungal activities of selected essential oils against Candida albicans: microscopic observations and chemical characterization of Cymbopogon citratus. BMC Complementary and Alternative Medicine. 2010; 10: 65.
[50]
Jiang Y, Wu N, Fu Y, Wang W, Luo M, Zhao C, et al. Chemical composition and antimicrobial activity of the essential oil of Rosemary. Environmental Toxicology and Pharmacology. 2011; 32: 63–68.
[51]
Kędzia A, Hołderna-Kędzia E. Effect of rosemary oil (Rosmarini aetheroleum) on yeastlike fungi. Postępy Fitoterapii. 2021; 22: 83–88.
[52]
Pina-Vaz C, Gonçalves Rodrigues A, Pinto E, Costa-de-Oliveira S, Tavares C, Salgueiro L, et al. Antifungal activity of Thymus oils and their major compounds. Journal of the European Academy of Dermatology and Venereology. 2004; 18: 73–78.
[53]
Sookto T, Srithavaj T, Thaweboon S, Thaweboon B, Shrestha B. In vitro effects of Salvia officinalis L. essential oil on Candida albicans. Asian Pacific Journal of Tropical Biomedicine. 2013; 3: 376–380.
[54]
Abu-Darwish MS, Cabral C, Ferreira IV, Gonçalves MJ, Cavaleiro C, Cruz MT, et al. Essential oil of common sage (Salvia officinalis L.) from Jordan: assessment of safety in mammalian cells and its antifungal and anti-inflammatory potential. BioMed Research International. 2013; 2013: 538940.
[55]
Benzaid C, Belmadani A, Djeribi R, Rouabhia M. The Effects of Mentha × piperita Essential Oil on C. albicans Growth, Transition, Biofilm Formation, and the Expression of Secreted Aspartyl Proteinases Genes. Antibiotics. 2019; 8: 10.
[56]
Agarwal V, Lal P, Pruthi V. Prevention of Candida albicans biofilm by plant oils. Mycopathologia. 2008; 165: 13–19.
[57]
Jafri H, Ahmad I. Thymus vulgaris essential oil and thymol inhibit biofilms and interact synergistically with antifungal drugs against drug resistant strains of Candida albicans and Candida tropicalis. Journal De Mycologie Medicale. 2020; 30: 100911.
[58]
Braga PC, Culici M, Alfieri M, Dal Sasso M. Thymol inhibits Candida albicans biofilm formation and mature biofilm. International Journal of Antimicrobial Agents. 2008; 31: 472–477.
[59]
Chandrasekaran CV, Srikanth HS, Anand MS, Allan JJ, Viji MMH, Amit A. Evaluation of the mutagenic potential and acute oral toxicity of standardized extract of Ocimum sanctum (OciBest™). Human & Experimental Toxicology. 2013; 32: 992–1004.
[60]
Jalilzadeh-Amin G, Maham M. Antidiarrheal activity and acute oral toxicity of Mentha longifolia L. essential oil. Avicenna Journal of Phytomedicine. 2015; 5: 128–137.
[61]
Oubihi A, Hosni H, Nounah I, Ettouil A, Harhar H, Alaoui K, et al. Phenolic Content, Antioxidant Activity, Anti-Inflammatory Potential, and Acute Toxicity Study of Thymus leptobotrys Murb. Extracts. Biochemistry Research International. 2020; 2020: 8823209.
[62]
Ramírez JH, Palacios M, Tamayo O, Jaramillo R, Gutiérrez O. Acute and subacute toxicity of Salvia scutellarioides in mice and rats. Journal of Ethnopharmacology. 2007; 109: 348–353.
[63]
Stojanović NM, Randjelović PJ, Mladenović MZ, Ilić IR, Petrović V, Stojiljković N, et al. Toxic essential oils, part VI: Acute oral toxicity of lemon balm (Melissa officinalis L.) essential oil in BALB/c mice. Food and Chemical Toxicology. 2019; 133: 110794.

Publisher’s Note: IMR Press stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share
Back to top